322 related articles for article (PubMed ID: 16478629)
21. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
22. [Concurrent weekly nedaplatin-based radiotherapy for high risk, recurrent and advanced cervical cancer].
Idei T; Sakamoto H; Nakajima Y; Hiraiwa Y; Takami N; Chishima F; Ohtani K; Nagaishi M; Yamamoto T; Kawamori J; Himi K; Tanaka Y
Gan To Kagaku Ryoho; 2003 Apr; 30(4):505-9. PubMed ID: 12722682
[TBL] [Abstract][Full Text] [Related]
23. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
Kobayashi Y; Ohara T; Wada Y; Okuda Y; Kondo H; Okuma Y; Suzuki N; Gomi H; Kiguchi K; Ishizuka B
J Obstet Gynaecol Res; 2009 Jun; 35(3):490-4. PubMed ID: 19527388
[TBL] [Abstract][Full Text] [Related]
24. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of preoperative concurrent chemoradiation therapy (CCRT) for locally advanced adenocarcinoma of cervix.
Shibata K; Kajiyama H; Yamamoto E; Terauchi M; Ino K; Nomura S; Nawa A; Kawai M; Kikkawa F
Eur J Surg Oncol; 2009 Jul; 35(7):768-72. PubMed ID: 18722747
[TBL] [Abstract][Full Text] [Related]
26. Combined chemotherapy and radiation for bulky stages I-II cervical cancer: comparison of concurrent and sequential regimens.
Park TK; Lee SK; Kim SN; Hwang TS; Kim GE; Suh CO; Loh JK
Gynecol Oncol; 1993 Aug; 50(2):196-201. PubMed ID: 8375735
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of alternating chemoradiotherapy consisting of extended-field dynamic conformational radiotherapy and systemic chemotherapy using 5-FU and nedaplatin for patients in high-risk group with cervical carcinoma.
Kodaira T; Fuwa N; Nakanishi T; Tachibana H; Nakamura T; Tomita N; Nakahara R; Inokuchi H
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):251-8. PubMed ID: 18513885
[TBL] [Abstract][Full Text] [Related]
28. Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
Gynecol Oncol; 2011 Jun; 121(3):542-5. PubMed ID: 21420157
[TBL] [Abstract][Full Text] [Related]
29. Intra-arterial chemotherapy with cisplatin followed by radical radiotherapy for locally advanced cervical cancer.
Sueyama H; Nakano M; Sakumoto K; Toita T; Takizawa Y; Moromizato H; Kakihana Y; Kushi A; Moromizato H; Higashi M
Gynecol Oncol; 1995 Dec; 59(3):327-32. PubMed ID: 8522249
[TBL] [Abstract][Full Text] [Related]
30. Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group.
DiSilvestro PA; Walker JL; Morrison A; Rose PG; Homesley H; Warshal D;
Gynecol Oncol; 2006 Dec; 103(3):1038-42. PubMed ID: 16889823
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA.
Kornovski Y; Gorchev G
J BUON; 2006; 11(3):291-7. PubMed ID: 17309152
[TBL] [Abstract][Full Text] [Related]
32. 20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy.
Song S; Song C; Kim HJ; Wu HG; Kim JH; Park NH; Song YS; Kim JW; Kang SB; Ha SW
Gynecol Oncol; 2012 Jan; 124(1):63-7. PubMed ID: 22004904
[TBL] [Abstract][Full Text] [Related]
33. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
[TBL] [Abstract][Full Text] [Related]
34. Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA).
Lee YY; Choi CH; Kim CJ; Song TJ; Kim MK; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
Gynecol Oncol; 2010 Mar; 116(3):459-63. PubMed ID: 20004008
[TBL] [Abstract][Full Text] [Related]
35. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results.
Liang JA; Chen SW; Chang WC; Hung YC; Yeh LS; Yang SN; Lin FJ
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):683-90. PubMed ID: 18676129
[TBL] [Abstract][Full Text] [Related]
36. Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma.
Adachi S; Ogasawara T; Wakimoto E; Tsuji Y; Takemura T; Koyama K; Takayasu Y; Inoue J; Nakao N
Cancer; 2001 Jan; 91(1):74-9. PubMed ID: 11148562
[TBL] [Abstract][Full Text] [Related]
37. Postoperative concurrent daily low-dose cisplatin-based chemoradiation improves the prognosis of patients with pathologic T2b or N1 cervical cancer.
Mitsuhashi A; Uno T; Usui H; Tate S; Hirashiki K; Kato K; Kiyohara H; Kato S; Ito H; Shozu M
Anticancer Res; 2010 Jun; 30(6):2341-6. PubMed ID: 20651390
[TBL] [Abstract][Full Text] [Related]
38. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
39. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer).
Classe JM; Rauch P; Rodier JF; Morice P; Stoeckle E; Lasry S; Houvenaeghel G;
Gynecol Oncol; 2006 Sep; 102(3):523-9. PubMed ID: 16504274
[TBL] [Abstract][Full Text] [Related]
40. [Neoadjuvant intraarterial chemotherapy with nedaplatin, peplomycin and mitomycin C for advanced cervical cancer].
Umeki H; Yamaguchi Y; Tsugata M; Wakana K; Somekawa Y; Shimabukuro K; Ohara M; Terauchi T; Ichimura M; Otsuka I; Aso T
Gan To Kagaku Ryoho; 2003 Mar; 30(3):377-82. PubMed ID: 12669397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
